Chemoinformaics analysis of Dimethyl methylsuccinate
| Molecular Weight | 160.169 | nRot | 3 |
| Heavy Atom Molecular Weight | 148.073 | nRig | 2 |
| Exact Molecular Weight | 160.074 | nRing | 0 |
| Solubility: LogS | -0.969 | nHRing | 0 |
| Solubility: LogP | 0.481 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 22.8995 |
| nHD | 0 | BPOL | 17.2465 |
| QED | 0.559 |
| Synth | 2.483 |
| Natural Product Likeliness | 0.638 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.116 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.502 |
| MDCK | 0.00014683 |
| BBB | 0.981 |
| PPB | 0.183519 |
| VDSS | 0.568 |
| FU | 0.788038 |
| CYP1A2-inh | 0.155 |
| CYP1A2-sub | 0.716 |
| CYP2c19-inh | 0.124 |
| CYP2c19-sub | 0.788 |
| CYP2c9-inh | 0.006 |
| CYP2c9-sub | 0.141 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.287 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.331 |
| CL | 9.062 |
| T12 | 0.91 |
| hERG | 0.008 |
| Ames | 0.025 |
| ROA | 0.018 |
| SkinSen | 0.459 |
| Carcinogencity | 0.049 |
| EI | 0.927 |
| Respiratory | 0.049 |
| NR-Aromatase | 0.027 |
| Antiviral | No |
| Prediction | 0.946804 |